Prime expert shares exciting enhancement to the Medical Pharmacy Trend Report

The American Journal of Managed Care (AJMC): At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection,...

Latest edition of Prime Therapeutics Report spotlights seismic shift in how best to diagnose and manage transthyretin amyloid cardiomyopathy (ATTR-CM) and what it means for patients, providers and...

After years of relatively limited therapeutic advancement, the bladder cancer treatment landscape is evolving rapidly. As the sixth most common cancer in the United States,1 bladder cancer is...

October 1, 2025 publications 2025 Medicaid Pharmacy Trend Report In the 2025 Medicaid Pharmacy trend report, we look back on the last 10 years of Medicaid pharmacy economics, providing data-based...

Looking for something? Patient login Already using Home Delivery by Prime Therapeutics Pharmacy? Log in here Mail Please take our survey and tell us how we're doing. [insert short link or use a...

Through our person-centered approach, we help coordinate care across multiple providers for members who are at risk for drug abuse or misuse. Targeted provider outreach 1 Mental illness. (March...

Manufacturer contact form Save a copy to your desktop and fill out the details. Access the form Louisiana Department of Health and Hospitals Louisiana Medicaid program Prior Authorization Schedule...

Expert staff Tap into our insurance expertise to ensure you get the most from your benefits. Specialized care Get info and help managing your condition from specially trained pharmacists and...

Tap into our Expert Clinical Network Prime received a request for a nonformulary biologic in a young patient with severe Crohn’s disease, as the provider documented past failures of a biologic on...

90-day supply Depending on plan design, you may be able to get a 90-day supply of your medicine for less than three 30-day fills. Registered pharmacists Dedicated pharmacists can help get your meds...

Learn how Prime champions cancer care through its industry-leading solutions, clinical insights, charitable giving and volunteer efforts

Recent studies have reported an incidence of TA-TMA spanning from 2% to 39%. Such wide variability is thought to stem from inconsistent diagnostic definitions as well as the inclusion of both...

August 26, 2026 Author: Caroline Quinn, PharmD, BCOP Few advances have shaped modern oncology more profoundly than the ability to match the right patient to the right therapy. Biomarkers play a...

Appetite For Change uses food as a tool to build health, wealth and social change. “For youth experiencing homelessness, the Prime Together Foundation’s donation helps The Bridge for Youth go...

References Ma L, Guo H, Zhao Y, et al. Liquid biopsy in cancer: current status, challenges and future prospects. Nature. 2024;9(336). McDowell S. Liquid biopsies: past, present, and future....

Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...

During the initial CAR T-cell therapy period, the total cost of care ranged from $350,000 to more than $2 million

Notice of privacy practices Effective Date: January 2026 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...

Education information Biometric information Legally protected classification characteristics We collect this information directly from you when you provide it by applying for a job, accepting a job...